Logomark

Gastroenterology

Pancreatitis

Pancreatitis is an inflammatory disorder of the pancreas that ranges in severity from mild, self-limiting cases to severe, life-threatening disease requiring intensive care. It is broadly categorized into acute pancreatitis (AP) and chronic pancreatitis (CP), both of which can lead to significant morbidity and mortality, particularly in critically ill patients.

Acute pancreatitis can result from various causes, including gallstones, alcohol use, and metabolic disturbances. Severe cases may progress to systemic inflammatory response syndrome (SIRS), multiorgan dysfunction, and necrotizing pancreatitis, necessitating aggressive supportive care, antimicrobial stewardship, and potential surgical intervention. Chronic pancreatitis, on the other hand, is characterized by persistent inflammation leading to fibrosis, pancreatic insufficiency, and long-term complications.

This section compiles key clinical guidelines and expert reviews to provide healthcare professionals with evidence-based strategies for the diagnosis, management, and treatment of pancreatitis. From initial assessment and risk stratification to advanced interventions in severe cases, these resources serve as a critical reference for optimizing patient outcomes.


Guideline

Acute pancreatitis management

International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025

IAP/APA/EPC/IPC/JPS Working Group, Pancreatology (2025)

What’s inside

The 2025 IAP/APA/EPC/IPC/JPS guidelines provide updated, evidence-based recommendations for the management of acute pancreatitis (AP), covering 18 domains and 96 clinical questions. Key updates include refined diagnostic criteria, severity prediction, fluid therapy, nutritional support, antibiotic use, and interventional strategies for necrotizing pancreatitis.

Why it’s relevant

Acute pancreatitis is a leading cause of gastrointestinal hospitalization, with severe cases carrying high morbidity and mortality. These guidelines standardize management across global centers, emphasizing early risk stratification, targeted interventions, and multidisciplinary care to improve outcomes and reduce complications.

Key focus

  • Diagnosis: Two of three criteria (abdominal pain, elevated enzymes, imaging findings)
  • Severity prediction: SIRS, CRP, IL-6, and persistent organ failure
  • Fluid therapy: Lactated Ringer’s solution, moderate infusion rates
  • Nutrition: Early oral/enteral feeding, polymeric formulations
  • Interventions: Step-up approach for infected necrosis, timing of drainage/necrosectomy
Previous
Nutritional support

Disclaimer

The information on this website is provided for informational and educational purposes only and is intended exclusively for use by medical professionals. It does not constitute professional medical advice, diagnosis, or treatment.

B-QON accepts no liability for decisions made or actions taken based on the information provided on this website. Users are responsible for verifying the accuracy and applicability of all content and for consulting qualified medical professionals before making any clinical decisions.

By using this website, you agree to these terms. For more information, please see our Terms and Conditions.